Paul Kaplowitz, MD, Endowed Lectureship

Established in 2015, the Paul Kaplowitz, MD, Endowed Lectureship is a collaborative initiative with  the American Academy of Pediatrics and the Pediatric Endocrine Society to recognize an individual for contributions to quality and cost-effective care in pediatric endocrinology.

This award is funded by the Paul Kaplowitz, MD, Endowment.

Award Recipients

2025 –

2024 – Todd Nebesio, MD 
Lecture: “Pubic Hair of Infancy - When History and Physical Trump Labs”

2023 – Amit Lahoti, MD
Lecture: “Developing Screening Protocols for Children with Premature Adrenarche”

2022 – Paul Kaplowitz, MD, PhD, FAAP
“My Journey as an Advocate for Cost-Effective Care in Pediatric Endocrinology"

2021 – Jennifer Raymond, MD, MCR
Lecture: “Caring for Young Adults with Type 1 Diabetes – Virtual Shared Medical Appointments”

2019 – Philippe F. Backeljauw, MD
Lecture:” Perspectives on Treatment for Girls with Central Precocious Puberty”

2018 – David Allen, MD
Lecture: “Growth Promoting Treatment: When Discretion is the Better Part of Value”

2017 – Karen Rubin, MD 
Lecture: “Expanding Access to Pediatric Endocrinology Care: A Core Quality Goal and Component of Population Health”

2016 – Joyce Lee, MD
Lecture: “Health Outcomes, Quality, and Cost: New Opportunities for Pediatric Endocrinology”

Paul Kaplowitz Abstract Award

New in 2025! The Paul Kaplowitz abstract award will recognize the best abstract by a trainee ( junior faculty, resident or medical student)  for a study designed to decrease the use of unnecessary tests, procedures and/or treatments in pediatric endocrinology that result in cost-effective care.  Abstracts may also consider studies to discuss co-management and how primary care and pediatric endocrinology can work together to decrease unnecessary testing and referral.  The recipient will receive a $1,000 honorarium.  

This award is funded by the Paul Kaplowitz, MD, Endowment.

Award Recipients

2025 - Alden Dewey, DO
Abstract: Incidence of Adrenal Pathology in Children referred for Premature Pubarche: a 9-year retrospective review in an Indiana cohort.

AAP and PES Leona Cuttler Quality Improvement Award

The AAP SOEn, in collaboration with the Pediatric Endocrine Society, offers an award in memory of Leona Cuttler and her extensive career as an advocate for children with endocrine disorders. The award is given to acknowledge the best abstract by a pediatric endocrine fellow, resident, or medical student on a topic that has a focus on Quality Improvement (QI) in Pediatric Endocrinology.

This award is funded through the AAP Section on Endocrinology.

Award Recipients

2025 - Daniel Hammond, MD
Abstract: Dia-beating Care Transitions: A Process Improvement Project for Preparation for Transition to Adult Care 

2024 - Lourdes-Morales-Dopico, MD, FAAP
Abstract: Does the Use of Free T4 by Equilibrium Dialysis in a Rescreening Protocol for Congenital Hypothyroidism in Very Low Birth Weight Newborns Decrease Repeated Testing?

2023 –  Erica Maris Wee, MD, FAAP
Abstract: Improving Transition to Adult Care Planning in a Diabetes Clinic: A Quality Improvement Initiative

2021 – Shoshana Tell, MD
Abstract: Improving Patient Access to Electronic Health Record Data and Reducing Disparities in Access

2020 – Alissa Guarneri, MD, FAAP
Abstract: Improving Diabetes Clinic Flow & Patient and Staff Satisfaction

2019 – Catherina Pinnaro, MD
Abstract: Simulation is an Effective Tool for Increasing Pediatric Resident Knowledge & Confidence in Managing Type 1 Diabetes (T1D)

2018 – Mackenzie Dean
Abstract: Redesigning Testosterone Prescribing in the Doernbecher Gender Clinic: Interdisciplinary Process Improvement Results in Enhanced Patient Experience

2017 – Kristina Cossen, MD
Abstract: Quality Improvement in the Perioperative Medical Management of Pediatric Thyroidectomy

2016 – Edward Bellfield, MD, MPH
Abstract: Systematic Depression Screening in Adolescents with Type 1 Diabetes: A Clinic-Based Quality Improvement Project

2015 – Allison Smego, MD
Abstract: Decreasing the time to insulin administration in hospitalized patients with cystic fibrosis related diabetes